Neutropenia
223 drugs220,208 FAERS reportsMedDRA PT
GET
/api/v1/reaction/neutropeniaReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D009503
A decrease in the number of NEUTROPHILS found in the blood.
Source: U.S. National Library of Medicine — MeSH (Neutropenia)
Drugs reporting Neutropenia (223)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Nogapendekin Alfa Inbakicept1034%
- 2Manganese Sulfate1620%
- 3Tetanus Toxin117%
- 4Clozapine18,81515%
- 5Eribulin52914%
- 6Ribociclib3,86913%
- 7Dextran 40913%
- 8Dexrazoxane10312%
- 9Penpulimab411%
- 10Sacituzumab47711%
- 11Trabectedin24411%
- 12Imetelstat1710%
- 13Lactobionate1510%
- 14Elivaldogene Autotemcel110%
- 15Vinorelbine6609.8%
- 16Mosunetuzumab809.6%
- 17Isatuximab4909.3%
- 18Ibritumomab Tiuxetan1419.3%
- 19Ifosfamide1,8829.0%
- 20Ceftaroline668.7%
- 21Ceftaroline Fosamil668.7%
- 22Filgrastim3,6038.7%
- 23Glofitamab1718.4%
- 24Obinutuzumab1,3128.3%
- 25Letrozole5,0188.3%
- 26Topotecan5578.2%
- 27Inavolisib317.8%
- 28Fulvestrant2,4377.6%
- 29Vinblastine1447.6%
- 30Mitoxantrone4647.5%
- 31Netupitant827.5%
- 32Pentostatin767.3%
- 33Uridine107.2%
- 34Uridine Triacetate107.2%
- 35Idecabtagene Vicleucel837.2%
- 36Adenine47.1%
- 37Palbociclib6,6637.1%
- 38Chlorambucil2747.0%
- 39Doxorubicin6,5377.0%
- 40Mesna5757.0%
- 41Ibutilide26.9%
- 42Etoposide5,0296.9%
- 43Levoleucovorin2456.9%
- 44Dacarbazine4916.8%
- 45Fluorouracil5,0756.8%
- 46Amisulpride3856.5%
- 47Ixabepilone686.5%
- 48Decitabine3196.5%
- 49Palonosetron3996.4%
- 50Thioguanine1346.4%
- 51Azacitidine1,8506.4%
- 52Lurbinectedin676.4%
- 53Pentamidine776.3%
- 54Cisplatin4,7906.3%
- 55Gemcitabine3,2306.3%
- 56Belinostat216.2%
- 57Polatuzumab Vedotin5576.1%
- 58Cytarabine3,6966.1%
- 59Bendamustine1,6316.1%
- 60Valganciclovir1,1146.0%
- 61Panitumumab9006.0%
- 62Cyclophosphamide10,3386.0%
- 63Vincristine1,7196.0%
- 64Carboplatin7,2825.9%
- 65Bleomycin5945.8%
- 66Pyrimethamine725.8%
- 67Dactinomycin1265.8%
- 68Brentuximab Vedotin5755.8%
- 69Leucovorin1,0665.8%
- 70Oxaliplatin4,1295.7%
- 71Venetoclax3,3395.6%
- 72Floxuridine85.6%
- 73Paclitaxel5,3295.6%
- 74Rasburicase1275.4%
- 75Ganciclovir5805.4%
- 76Retifanlimab25.4%
- 77Clofarabine1215.4%
- 78Gemtuzumab Ozogamicin1905.3%
- 79Ziftomenib15.3%
- 80Lomustine1305.2%
- 81Palifermin205.2%
- 82Fludarabine1,9745.2%
- 83Anidulafungin805.1%
- 84Nelarabine485.1%
- 85Axicabtagene Ciloleucel4715.0%
- 86Melphalan1,2345.0%
- 87Docetaxel3,2995.0%
- 88Cedazuridine385.0%
- 89Temozolomide1,0265.0%
- 90Asparaginase155.0%
- 91Irinotecan6115.0%
- 92Goserelin6374.9%
- 93Daratumumab2,0004.9%
- 94Loncastuximab Tesirine174.8%
- 95Cabazitaxel1664.8%
- 96Pralatrexate314.8%
- 97Manganese184.7%
- 98Pegaspargase5694.7%
- 99Glasdegib224.7%
- 100Foscarnet1844.7%
- 101Granisetron5604.7%
- 102Idarubicin504.6%
- 103Posaconazole7244.6%
- 104Pemetrexed1,6894.6%
- 105Treosulfan1164.6%
- 106Carmustine2054.5%
- 107Epirubicin2734.4%
- 108Teclistamab864.4%
- 109Thiotepa4074.4%
- 110Vorinostat934.3%
- 111Amifostine354.3%
- 112Uranium444.3%
- 113Ramucirumab2614.3%
- 114Tafasitamab374.3%
- 115Ceftazidime3214.2%
- 116Fosfomycin244.2%
- 117Deferiprone1214.1%
- 118Rifabutin1164.1%
- 119Talquetamab754.1%
- 120Inotuzumab Ozogamicin1174.1%
- 121Tisagenlecleucel1814.1%
- 122Dexchlorpheniramine404.0%
- 123Demeclocycline94.0%
- 124Cetuximab1,2133.9%
- 125Carfilzomib1,0923.9%
- 126Dexamethasone11,7173.9%
- 127Chlorpromazine2653.8%
- 128Elotuzumab1923.8%
- 129Calaspargase Pegol253.8%
- 130Plerixafor543.7%
- 131Danazol1033.7%
- 132Primaquine33.7%
- 133Romidepsin613.7%
- 134Daunorubicin1293.5%
- 135Platinum363.5%
- 136Gilteritinib1323.5%
- 137Cefepime5453.5%
- 138Mercaptopurine5923.5%
- 139Cefotaxime1473.5%
- 140Mitotane603.5%
- 141Zoledronic Acid1,3393.4%
- 142Capecitabine3,0823.4%
- 143Piperacillin1,1183.4%
- 144Clemastine453.4%
- 145Telavancin43.4%
- 146Alemtuzumab6443.4%
- 147Tazobactam1,1263.4%
- 148Mitomycin1073.3%
- 149Micafungin2753.3%
- 150Flucytosine443.3%
- 151Pertuzumab1,0093.3%
- 152Pomalidomide3,2703.3%
- 153Daptomycin2833.2%
- 154Trifluridine3493.2%
- 155Elranatamab283.2%
- 156Idelalisib2243.2%
- 157Abemaciclib5963.2%
- 158Bevacizumab4,0153.2%
- 159Talazoparib543.2%
- 160Sulfamethoxazole2,6103.2%
- 161Glucarpidase113.2%
- 162Basiliximab3563.1%
- 163Interleukin-10113.1%
- 164Interleukin-11113.1%
- 165Interleukin-3113.1%
- 166Interleukin-5113.1%
- 167Tipiracil3223.1%
- 168Lapatinib4703.1%
- 169Cidofovir423.0%
- 170Trimethoprim2,8063.0%
- 171Zinc Sulfate843.0%
- 172Miltefosine113.0%
- 173Procarbazine1322.9%
- 174Meropenem9132.9%
- 175Megestrol1102.9%
- 176Trastuzumab2,5052.9%
- 177Selinexor2422.9%
- 178Acamprosate92.9%
- 179Acyclovir3,1862.8%
- 180Fluconazole1,8892.7%
- 181Amphotericin5522.7%
- 182Amphotericin B5522.7%
- 183Momelotinib322.7%
- 184Atovaquone2672.7%
- 185Pegfilgrastim2,7142.7%
- 186Interferon Gamma-1b372.7%
- 187Valproate5362.7%
- 188Nafcillin242.6%
- 189Lisocabtagene Maraleucel212.6%
- 190Sargramostim442.6%
- 191Deferoxamine552.6%
- 192Ivosidenib502.6%
- 193Itraconazole2982.6%
- 194Zidovudine5062.5%
- 195Busulfan4552.5%
- 196Ethambutol642.5%
- 197Letermovir722.4%
- 198Enfortumab1572.4%
- 199Voriconazole7162.4%
- 200Oxacillin262.4%
- 201Ixazomib6712.4%
- 202Temsirolimus1062.4%
- 203Enoxaparin1,3262.3%
- 204Valacyclovir1,5732.3%
- 205Thalidomide8322.3%
- 206Vancomycin1,4732.3%
- 207Pembrolizumab2,2512.2%
- 208Ciltacabtagene Autoleucel1132.2%
- 209Lenalidomide9,0832.2%
- 210Erlotinib2652.1%
- 211Dostarlimab432.1%
- 212Atezolizumab7982.1%
- 213Ceftriaxone7772.1%
- 214Epcoritamab232.0%
- 215Entecavir2191.9%
- 216Sirolimus2471.9%
- 217Prednisolone3,4611.8%
- 218Cladribine1701.8%
- 219Amivantamab501.7%
- 220Isavuconazonium551.6%
- 221Epinastine171.5%
- 222Blinatumomab311—
- 223Brexucabtagene Autoleucel48—
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Febrile Neutropenia127 shared · 0.50
- Thrombocytopenia147 shared · 0.48
- Anaemia166 shared · 0.32
- Sepsis104 shared · 0.31
- Pancytopenia75 shared · 0.31
- Disease Progression103 shared · 0.29
- Platelet Count Decreased80 shared · 0.27
- White Blood Cell Count Decreased61 shared · 0.25
- Malignant Neoplasm Progression68 shared · 0.22
- Pyrexia199 shared · 0.22
Literature
Recent PubMed references pinned to Neutropenia as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Neurological manifestations in Wiskott-Aldrich syndrome: a systematic review.Frontiers in immunology · 2026 · Raccagni NG, Milanesi VF, Lucchini G, et al.PMID 42183254DOI 10.3389/fimmu.2026.1829058
- High donor hemoglobin interacts with pre-transplant recipient neutropenia to modulate mortality after allogeneic hematopoietic stem cell transplantation: An exploratory, single-center, retrospective, real-world study.PloS one · 2026 · Eslami M, Mehrabi M, Payandeh M, et al.PMID 42172258DOI 10.1371/journal.pone.0349615
- Obinutuzumab-induced acute thrombocytopenia and leukopenia in ANCA-associated glomerulonephritis: case report and literature review.Frontiers in immunology · 2026 · Jin Y, Huang Y, He X, et al.PMID 42164499DOI 10.3389/fimmu.2026.1845580
- [Chinese guidelines for the clinical application of antibacterial drugs for febrile neutropenia (2026)].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2026 · Chinese Society of Hematology, Chinese Medical Association, Chinese Medical Doctor Association, Hematology BranchPMID 42161653DOI 10.3760/cma.j.cn121090-20260120-00041
- Mapping supportive-care evidence for febrile neutropenia prevention in breast cancer chemotherapy: a bibliometric analysis of long-acting G-CSF prophylaxis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026 · Li S, Shang Y, Yuan X, et al.PMID 42149261DOI 10.1007/s00520-026-10780-1
- MASCC score and neutropenic complications: what is the likelihood?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026 · Davis MPPMID 42142265DOI 10.1007/s00520-026-10786-9
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.